GlassScriptPhysician profile
Tanya I Bryant
NPI 1194739987
$2,348.76
in general payments reported to CMS, 2019-2025
21 companies · $489 in 2025
The $489 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $157 · 2021: $432 · 2022: $328 · 2023: $188 · 2024: $448 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,124.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $912.09 | 2023-2025 | |
| Abbvie INC. | $276.44 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $226.88 | 2021-2022 | |
| Allergan, INC. | $202.13 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $201.29 | 2019-2025 | Farxiga |
| Novo Nordisk INC | $111.69 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $66.17 | 2021-2025 | Zoryve |
| Phathom Pharmaceuticals, INC. | $63.50 | 2024-2025 | Voquezna |
| Amgen INC. | $44.89 | 2019 | |
| Novartis Pharmaceuticals Corporation | $38.45 | 2019-2020 | |
| Cmp Pharma, INC. | $30.44 | 2021 | |
| Viiv Healthcare Company | $28.02 | 2024 | Apretude |
| Mylan Specialty L.P. | $21.11 | 2022 | |
| Pfizer INC. | $20.62 | 2019 | |
| Janssen Pharmaceuticals, INC | $18.73 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $17.71 | 2022 | |
| Merck Sharp & Dohme LLC | $15.97 | 2019 | |
| Glaxosmithkline, LLC. | $15.75 | 2023 | Pediarix, Bexsero, Shingrix |
| Arbor Pharmaceuticals, INC. | $13.30 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $12.25 | 2021 | |
| Nestle Healthcare Nutrition INC. | $11.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tanya Bryant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.